Axxess, CellTrak expand EVV partnership
Dallas-based Axxess, a home health technology company, plans to expand its partnership with CellTrak to provide electronic visit verification (EVV) to more home health and home care providers in the United States.
Schaumburg, Illinois-based CellTrak is a software company that provides care delivery management solutions used by more than 4,000 home care agencies in the U.S., Canada and the United Kingdom.
Axxess is a developer of cloud-based software solutions in home health, home care and hospice. For Axxess, expanding its partnership with CellTrak will allow it to deliver more value to more clients, founder and CEO John Olajide believes.
“CellTrak’s EVVLink enables connection to multiple state aggregators where our clients are located across the country, and provides the technology and seamless integration to ensure the requirements of the 21st Century Cures Act are met,” Olajide said in a statement.
EVV is mandated by the 21st Century Cures Act, legislation designed to help accelerate and streamline medical product developments to patients in need.
In other recent Axxess news, the company announced Wednesday that it has reached a major milestone. More than 10,000 visits have now been completed by clinicians accepting postings by agencies through AxxessCARE, the scheduling and staffing solution currently available to Axxess clients in Texas, Illinois, Florida and Massachusetts.
LHC Group turns to predictive-analytics tool
Lafayette, Louisiana-based LHC Group Inc. (Nasdaq: LHCG) has announced plans to expand its partnership with Medalogix by initiating implementation of Medalogix Bridge in multiple markets. Medalogix Bridge is a software solution that attempts to leverage data to identify patients with a high risk of mortality.
The first wave of implementation of Medalogix Bridge should be finalized during the first quarter of 2020. LHC Group will also expand its use of Medalogix Nurture, which attempts to leverage data to identify discharged patients in need of additional care.
Nashville, Tennessee-based Medalogix is a predictive analytics company focused on the home health industry. In June, Encompass Health (NYSE: EHC) made a minority investment in it. Amedisys Inc. (Nasdaq: AMED) is another minority investor.
On a high level, the use of Bridge is in-line with LHC Group’s goals of becoming even more strategic in 2020. Chairman and CEO Keith Myers spoke with Home Health Care News about those goals and other topics earlier this month.
Androscoggin Home Healthcare receives USDA telehealth grant
The U.S. Department of Agriculture has awarded Androscoggin Home Healthcare + Hospice a $254,000 grant, which will allow the provider to buy and install 250 more remote monitoring systems and expand its telehealth services.
The Lewiston, Maine-based company will deploy the additional systems to the homes of patients with chronic and serious illnesses in central and western Maine. The grant was awarded by the USDA’s Rural Development program.
Founded in 1966, Androscoggin is one of Maine’s largest independent, nonprofit home health care organizations. It provides home health, hospice and care management services. The grant will give the company the opportunity to reduce hospital readmissions in some places and innovate in others, according to CEO Ken Albert.
“The research is clear: Telemonitoring is a proven strategy for managing chronic illness that benefits patients, families and the overall effectiveness of the health care delivery team,” Albert said in a statement. “Telehealth monitoring will also allow us to be innovative in other types of care delivery like preeclampsia in pregnancy.”
Androscoggin already collaborated with telehealth providers to serve 1,800 patients through telemonitoring services in 2018, according to a report from Mainebiz.